Additional European Equity News

Arkema (AKE FP) - Signs agreement with EDF renewables for supply of renewable electricity covering 70% of Bostik's needs in France. (Newswires) 

Evotec (EVT GY) - Glycotope and Evotc enter licensing agreement to combine Glycotope antibodies and Evotec's immune cell engage platform. (Newswires) 

Ferrovial (FER SM) - Reports Heathrow Nov passengers 6.13mln, +10.2% YY. (Newswires) 

GSK (GSK LN) - GSK's Jemperli plus chemotherapy approve as the first and only frontline immuno-oncology treatment in the EU for dMMR/MSI-H primary advanced of recurrent endometrial cancer. (Newswires) 

Iberdrola (IBE SM) - Awarded a second power storage contract in Australia, via El Economista. (Newswires)

MorphoSys (MOR GY) – Pelabresib improves all four hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 study. (Newswires)

Saint Gobain (SGO FP) - Renewed a EUR 4bln bank commitment with a backup sustainability-linked revolving credit facility. (Newswires)

Sodexo (SW FP) - Co. and Harris Interactive reveal the results of the first international sustainable food barometer. (Newswires) 

Vistry (VTY LN) - Commences GBP 55mln share buyback. (Newswires) 

Anglo American (AAL LN) downgraded to Neutral from Outperform at Oddo

ArcelorMittal (MT NA) upgraded to Outperform from Neutral at Oddo

Beiersdorf (BEI GY) downgraded to Market Perform from Outperform at Bernstein

Orkla (ORK NO) downgraded to Underperform from Market Perform at Bernstein 

Reckitt (RKT LN) upgraded to Outperform from Market Perform at Bernstein

Unilever (ULVR LN) upgraded to Market Perform from Underperform at Bernstein